Literature DB >> 12506772

Muscle biopsy findings in inflammatory myopathies.

Marinos C Dalakas1.   

Abstract

The inflammatory myopathies encompass a heterogeneous group of acquired muscle diseases characterized clinically, by muscle weakness, and histologically, by inflammatory infiltrates within the skeletal muscles. The group of these myopathies comprise three major and discrete subsets: polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM). Each subset retains its characteristic clinical, immunopathologic, and morphologic features regardless of whether it occurs separately or in connection with other systemic diseases. Although the diagnosis of these disorders is based on the combination of clinical examination, electromyographic data, serum muscle enzyme levels, various autoantibodies, and the muscle biopsy findings, the muscle biopsy offers the most definitive diagnostic information in the majority of the cases. This article summarizes the main histologic features that characterize PM, DM, or IBM and emphasizes the main pitfalls associated with interpretation of the biopsies.

Entities:  

Mesh:

Year:  2002        PMID: 12506772     DOI: 10.1016/s0889-857x(02)00030-3

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  28 in total

1.  Development of an improved animal model of experimental autoimmune myositis.

Authors:  Juan Kang; Hong-Ya Zhang; Guo-Dong Feng; Dong-Yun Feng; Hong-Ge Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

Review 3.  [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis].

Authors:  E Genth
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

4.  Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Frederick W Miller
Journal:  JAMA       Date:  2011-01-12       Impact factor: 56.272

5.  AIIMDs: An Integrated Framework of Automatic Idiopathic Inflammatory Myopathy Diagnosis for Muscle.

Authors:  Manish Sapkota; Fujun Liu; Yuanpu Xie; Hai Su; Fuyong Xing; Lin Yang
Journal:  IEEE J Biomed Health Inform       Date:  2017-04-13       Impact factor: 5.772

Review 6.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

7.  Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.

Authors:  Peter Szodoray; Philip Alex; Nicholas Knowlton; Michael Centola; Igor Dozmorov; Istvan Csipo; Annamaria T Nagy; Tamas Constantin; Andrea Ponyi; Britt Nakken; Katalin Danko
Journal:  Rheumatology (Oxford)       Date:  2010-06-29       Impact factor: 7.580

8.  Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.

Authors:  N A Goyal; T M Cash; U Alam; S Enam; P Tierney; N Araujo; F H Mozaffar; A Pestronk; T Mozaffar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-09       Impact factor: 10.154

9.  Multi-parametric MRI characterization of inflammation in murine skeletal muscle.

Authors:  Nathan D Bryant; Ke Li; Mark D Does; Stephanie Barnes; Daniel F Gochberg; Thomas E Yankeelov; Jane H Park; Bruce M Damon
Journal:  NMR Biomed       Date:  2014-04-29       Impact factor: 4.044

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.